AEMDA: inferring miRNA-disease associations based on deep autoencoder

MOTIVATION MicroRNAs (miRNAs) are a class of noncoding RNAs that play critical roles in various biological processes. Many studies have shown that miRNAs are closely related to the occurrence, development and diagnosis of human diseases. Traditional biological experiments are costly and time consuming. As a result, effective computational models have become increasingly popular for predicting associations between miRNAs and diseases, which could effectively boost human disease diagnosis and prevention. RESULTS We propose a novel computational framework, called AEMDA, to identify associations between miRNAs and diseases. AEMDA applies a learning-based method to extract dense and high-dimensional representations of diseases and miRNAs from integrated disease semantic similarity, miRNA functional similarity and heterogeneous related interaction data. In addition, AEMDA adopts a deep autoencoder that does not need negative samples to retrieve the underlying associations between miRNAs and diseases. Furthermore, the reconstruction error is used as a measurement to predict disease-associated miRNAs. Our experimental results indicate that AEMDA can effectively predict disease-related miRNAs and outperforms state-of-the-art methods. AVAILABILITY The source code and data are available at https://github.com/CunmeiJi/AEMDA. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.

[1]  Cheng Liang,et al.  A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..

[2]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[3]  Hao Sun,et al.  Inferring the Disease-Associated miRNAs Based on Network Representation Learning and Convolutional Neural Networks , 2019, International journal of molecular sciences.

[4]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[5]  Jianye Hao,et al.  A learning-based framework for miRNA-disease association identification using neural networks , 2018, bioRxiv.

[6]  C. C. Zhang,et al.  The common variants implicated in microstructural abnormality of first episode and drug-naïve patients with schizophrenia , 2017, Scientific Reports.

[7]  Hsien-Da Huang,et al.  miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..

[8]  Laiyi Fu,et al.  A deep ensemble model to predict miRNA-disease association , 2017, Scientific Reports.

[9]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.

[10]  Q. Cui,et al.  Benchmark of computational methods for predicting microRNA-disease associations , 2019, Genome Biology.

[11]  Wei Tang,et al.  dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers , 2016, Nucleic Acids Res..

[12]  Xing Chen,et al.  MicroRNAs and complex diseases: from experimental results to computational models , 2019, Briefings Bioinform..

[13]  Hinrich Schütze,et al.  Introduction to information retrieval , 2008 .

[14]  V. Ambros microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[15]  Lawrence D. Jackel,et al.  Backpropagation Applied to Handwritten Zip Code Recognition , 1989, Neural Computation.

[16]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[17]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[18]  Yuan Zhou,et al.  HMDD v3.0: a database for experimentally supported human microRNA–disease associations , 2018, Nucleic Acids Res..

[19]  Shanshan Zhao,et al.  miR‐126‐3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/&bgr;‐catenin signaling via targeting SOX2 , 2019, Life sciences.

[20]  Zhen Gao,et al.  Graph regularized L2,1-nonnegative matrix factorization for miRNA-disease association prediction , 2020, BMC Bioinformatics.

[21]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[22]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[23]  Howard Y. Chang,et al.  PIRCh-seq: functional classification of non-coding RNAs associated with distinct histone modifications , 2019, Genome Biology.

[24]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[25]  Chenggang Clarence Yan,et al.  SACMDA: MiRNA-Disease Association Prediction with Short Acyclic Connections in Heterogeneous Graph , 2018, Neuroinformatics.

[26]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[27]  Lei Wang,et al.  BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[28]  Chenggang Clarence Yan,et al.  Predict MiRNA-Disease Association with Collaborative Filtering , 2018, Neuroinformatics.

[29]  C. Croce,et al.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.

[30]  Weixiong Zhang,et al.  A non-negative matrix factorization based method for predicting disease-associated miRNAs in miRNA-disease bilayer network , 2017, Bioinform..

[31]  Xing Chen,et al.  DRMDA: deep representations‐based miRNA–disease association prediction , 2017, Journal of cellular and molecular medicine.

[32]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.

[33]  Xiangxiang Zeng,et al.  Prediction of potential disease-associated microRNAs using structural perturbation method , 2017, bioRxiv.

[34]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.